Dosing Frequency for Buscopan in a 6-Year-Old Child
Buscopan (hyoscine butylbromide) may be administered to a 6-year-old child at a dose of 10 mg orally, which can be repeated as needed for symptom relief, though specific pediatric dosing intervals are not explicitly defined in the available evidence.
Evidence-Based Dosing Guidance
The available evidence provides limited specific guidance on dosing frequency for hyoscine butylbromide in pediatric patients:
Approved Pediatric Use
- Hyoscine butylbromide is approved for use in children aged 6 years and older 1
- A randomized controlled trial in children aged 8-17 years used 10 mg given orally as a single dose for nonspecific colicky abdominal pain 2
- This study demonstrated clinically important pain reduction with good safety profile 2
Safety Profile in Children
The comprehensive review of HBB in childhood demonstrates:
- Safety data exists for children as young as 2 days old in off-label uses 1
- The overall evidence from thousands of patients supports safety and tolerability in childhood, including those younger than 6 years 1
- No serious adverse effects were observed in the pediatric emergency department trial 2
- Adverse effects occurred in approximately 28% of children but were not serious 2
Practical Dosing Recommendations
For a 6-Year-Old Child:
- Initial dose: 10 mg orally
- Repeat dosing: Can be given as needed for symptom relief
- The evidence suggests single-dose efficacy, with rescue analgesia needed in only 3.3% of cases 2
Important Caveats:
- No maximum daily dose or minimum interval between doses is specified in the pediatric literature reviewed
- Adult formulations typically allow dosing up to 3-4 times daily, but pediatric-specific frequency guidelines are lacking
- The drug's quaternary ammonium structure limits CNS penetration, contributing to its favorable safety profile 1
Clinical Considerations:
- Both hyoscine butylbromide and acetaminophen showed similar efficacy, with mean pain scores of 29 mm vs 30 mm on a 100 mm visual analogue scale at 80 minutes 2
- Approximately 55% of children achieved pain scores <30 mm at 80 minutes 2
- The medication should be used for approved indications (abdominal cramps and pain) in this age group
Given the lack of specific pediatric dosing interval guidelines, a conservative approach would be to allow repeat dosing every 6-8 hours as needed, not exceeding 3-4 doses in 24 hours, extrapolating from adult dosing patterns while maintaining the 10 mg pediatric dose.